Tethering Transposons

Panoramix, a newly identified transcription repressor, takes the bounce out of jumping genes.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Drosophila melanogasterWIKIMEDIA, ANDRÉ KARWATHMost genomes harbor unruly, mobile DNA elements that can cause potentially harmful mutations. Transposons—thought to be related to viruses—can copy themselves and insert randomly around the genome. A paper published today (October 15) in Science provides a greater understanding of how cells shut down these rogue jumping genes. Greg Hannon of the Cancer Research UK Cambridge Institute and his colleagues have identified a protein in fruit flies that appears to halt transposons before they begin to leap.

“This is a mountain of impressive work, a huge amount of data, [the result of which] is that we now understand something about how piRNAs are transcriptionally silencing their targets,” said molecular geneticist Keith Slotkin of Ohio State University who was not involved in the work. “We knew that this was happening, but the mechanism was all question marks and hand-waving.”

Piwi-interacting RNAs, or piRNAs, are short noncoding RNAs that, as their name implies, interact with a protein called Piwi—a highly conserved transposon-suppressing factor. To protect the host against damaging tranposon-induced mutations, Piwi-piRNA complexes both destroy transposon transcripts in the cytoplasm (post-transcriptional silencing) and block transposon transcription in the nucleus (transcriptional silencing). Essentially, the piRNA pathway “mops up the water” and “turns off the spigot,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies